Navigation Links
Apieron Strengthens Senior Leadership With Commercial, Financial Appointments
Date:5/19/2009

MENLO PARK, Calif., May 19 /PRNewswire/ -- Apieron, Inc. (www.apieron.com) significantly strengthened its senior management team with the appointment of Steve Bubrick as Vice President, Sales & Marketing, and Bryan Miller as Vice President, Finance. Both appointments are effective immediately.

Mr. Bubrick has more than 20 years of operational and commercial experience in the consumer medical device industry, mainly in diabetes management. Prior to joining Apieron, Mr. Bubrick was the Vice President of Customer Care & Reimbursement for Bedford, Massachusetts-based Insulet Corp., where he contributed to the company's 170% revenue growth in 2008. Before joining Insulet, Mr. Bubrick was Director, Worldwide Marketing for in-vivo products at Abbott Diabetes Care, which was formed by Abbott's acquisition of TheraSense, at which he was a commercial and R&D director. Prior to TheraSense, Mr. Bubrick held numerous commercial and international roles at LifeScan Inc., a division of Johnson & Johnson. Steve earned his BA at the University of California, Berkeley.

"We see many parallels between the self glucose testing and eNO monitoring markets," said Holly McGarraugh, Apieron CEO. "Steve understands how to grow a start up business like Apieron through great marketing and customer relations. His leadership will play a strategically important role in understanding our markets, serving our customers and driving sales of the Insight eNO System. With Bryan filling a critical financial leadership role, and Steve joining us to focus our commercial efforts, we've significantly increased the depth and experience on the senior management team."

Mr. Miller most recently served as a Principal at Berkshire Financial Management LLC where he handled financial and management consulting and equity management of properties in California, Nevada and Arizona. Prior to that, Mr. Miller was the Senior Director of Finance at eV3, (FoxHollow Technologies, Inc.) the medical device company, where he was responsible for financial planning, forecasting and analysis as well as internal reporting. Mr. Miller has an extensive background in financial leadership roles, having held additional senior positions with Trimble Navigation, Shopping the Globe, Inc. and Sega of America. He earned his MBA at Stanford University Graduate School of Business and his BS at University of California, Los Angeles

About the Insight eNO System

The Insight eNO System has been available for use in the physicians' office since March 2008. The system uses a proprietary biosensor technology to measure exhaled nitric oxide, a well established indicator of asthma severity and steroid responsive airway inflammation. Measuring eNO and determining the level of airway inflammation can help clinicians more closely manage their patients' asthma and therefore more precisely titrate medications, which can lead to fewer asthma exacerbations.

About Apieron Inc.

Apieron Inc. is a private, venture-backed medical device company based in Menlo Park, CA that was formed in early 2001 to develop a simple-to-use, non-invasive monitor for the measurement of exhaled nitric oxide (eNO) for the management of asthma. The Apieron biosensor technology platform utilizes a patented technology that allows for the highly sensitive detection of selected analytes like eNO. Apieron is committed to collaborating with physicians and patients to develop innovative medical solutions to improve quality of life and standards of care.

    Contact:
    Steve DiMattia
    (646) 201-5445


'/>"/>
SOURCE Apieron, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. frog design Strengthens Creative Leadership With New Appointments
2. China YCT International (OTCBB: CYIG) Strengthens Corporate Governance With Establishment of Audit Committee and Appointments of Three New Independent Directors
3. Sparta Systems Strengthens TrackWise(R) Enterprise Class Quality Management Solution with Robust Web Services Capabilities
4. NexBio Completes First-in-Man Clinical Trial With DAS181 (Fludase(R)) and Strengthens Clinical Leadership
5. Pharos Innovations Strengthens Leadership Team, Informatics Program
6. LifeSecure Insurance Company Strengthens National Footprint with Partnership Program Approvals in Six States
7. Globus Medical Strengthens Executive Team with Appointment of CFO
8. Duane Reade Holdings, Inc. Further Strengthens Management Team With Addition of Frank Scorpiniti, SVP, Pharmacy Operations
9. Study strengthens link between tobacco smoke and behavioral problems in boys with asthma
10. Innerscope Research Strengthens Management Team With Three Executive Appointments
11. New evidence strengthens link between cigarette smoke exposure and poor infant health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, ... with the grand opening of the Sober College Robert Pfeifer Memorial Learning Center ... December 2-3, and was attended by an overwhelming amount of alumni, family, colleagues ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and ... results of its phase 3 EXPEDITION3 trial at the ... meeting. As previously disclosed, solanezumab did not meet the ... of solanezumab initiated in people with mild dementia due ... regulatory submissions for solanezumab for the treatment of mild ...
(Date:12/8/2016)... de dezembro de 2016  A Mederi Therapeutics Inc . anunciou aprovação ... não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto -  ... ... Live Stretta procedure performed and broadcast during the Chinese ... Union Hospital , ...
(Date:12/8/2016)... Pa. , Dec. 8, 2016  Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...
Breaking Medicine Technology: